Quality and safety requirements for sustainable phage therapy products

HIGHLIGHTS

• who: Pharm Res ( et al. from the JGabard : F. Pouilot Pherecydes Pharma, Romainville, France have published the research work: Quality and Safety Requirements for Sustainable Phage Therapy Products, in the Journal: (JOURNAL) of 14/01/2015
• future: More research is urgently needed to gather the required data with regard to the efficacy of phage therapy and to broaden the understanding of bacteria-phage coevolution in nature and in the context of human disease . It is however expected that fast low-cost and accurate full genome sequencing and analysis (of bacteriophages) will replace routine microbial genotyping . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.